Cardio Diagnostics Holdings, Inc. CDIO

Set alert

Price alert · CDIO

All alert types
1.66 USD -0.01 -0.60%

As of Nov 3, 11:08 AM ET

Bid
1.64 × 1
Ask
1.67 × 1
1.60 Day range 1.67
0.97 52-week range 7.91
YTD
-38.75%
1 year
-58.29%
Open
1.60
Prev close
1.67
Mkt cap
4.94M
Vol
1.40K
Avg vol
36.07K
EPS
-2.91
P/E
0.00
Div yield
0.00%
More statistics
Low
1.60
High
1.67
Forward P/E
-4.12
Beta
4.68
Short ratio
0.70
Inst. own
4.15%
Dividend
0.00
Ex-div date
Earnings
Jul 1, 2024
50-d avg
0.44336
200-d avg
0.598455
1y target
2.00

1M chart

Chart tools
Interval

Signals (12)
NameDateAgo
SMA: BearishOct 30, 20264 days ago
MACD: Sell SignalOct 30, 20264 days ago
SMA: BullishOct 29, 20265 days ago
MACD: Buy SignalOct 29, 20265 days ago
SMA: BearishOct 27, 20261 week ago
SMA: BullishOct 26, 20261 week ago
SMA: BearishOct 22, 20261 week ago
SMA: BullishOct 21, 20261 week ago
SMA: BearishOct 8, 20263 weeks ago
SMA: BearishOct 8, 20263 weeks ago
MACD: Sell SignalOct 8, 20263 weeks ago
MACD: Buy SignalOct 5, 20264 weeks ago

Analyst view

Price target (mean) 2.00
Ratings (0m) 1 1 buy · 0 hold · 0 sell
  • Strong buy0
  • Buy1
  • Hold0
  • Sell0
  • Strong sell0

Recommendation trend

  • This month 1
  • 1 month ago 1

Earnings and revenue estimates

Consensus for the coming quarters and fiscal years

CDIO analyst estimates
PeriodEPS estimateLow – highYear agoEPS growthRevenue estimateRevenue growthAnalysts
Current quarter-0.06-0.06 – -0.06-1.06+94.4%25.00K+370.8%1
Next quarter-0.06-0.06 – -0.06-0.20+70.0%50.00K+213.9%1
Current year-0.36-0.36 – -0.36-1.10+67.3%55.00K+222.2%1
Next year-0.23-0.23 – -0.23-0.36+36.1%525.00K+854.6%1

Upgrades and downgrades

The latest rating changes

CDIO analyst upgrades and downgrades
DateFirmActionFromTo
Aug 27, 2024BenchmarkReiteratedSpeculative BuySpeculative Buy
Jun 6, 2024BenchmarkMaintainedSpeculative BuySpeculative Buy
Apr 19, 2024BenchmarkMaintainedSpeculative BuySpeculative Buy
Jun 15, 2023BenchmarkReiteratedSpeculative BuySpeculative Buy
May 22, 2023Northland Capital MarketsInitiated—Outperform
Apr 18, 2023BenchmarkReiterated—Speculative Buy